Production of electroporation device and buffer

The development of electroporation device and buffer made great progress. The buffer has been developed by partner 3P and will be now evaluated for in vitro and in vivo experiments with regard to the clinical trials. Moreover, the electroporation device, the so-called Cliniporator, which promotes the integration process of the therapeutic gene sequence into the patient cells, has been adapted to TargetAMD purposes. The micro-cuvettes, needed accessory for the Cliniporator, have been refined by IGEA and distributed to the partners.

10. February 2015
Categories: Target AMD